close

Agreements

1 219 220 221 222 223 246
Number of results: 4911

PDF print is not allowed for data more than 3000.Please search above for fewer data.

Date Company Compound Disease Type of agreement Therapeutic area Type of Information
2012-05-23 Selexis (Switzerland) Fusion Antibodies Services (UK) bioproduction services (antibody humanization, generation of CHO cell lines...) Services contract
2012-05-21 Ventana Medical Systems, a member of the Roche Group (USA - Switzerland) Gen-Probe (USA) ERG biomarker (measure of ERG protein expression through immunohistochemistry (IHC) in prostate tissue) prostate cancer

licensing

Cancer - Oncology Licensing agreement
2012-05-21 Provence Technologies (France) Neuroptis Biotech (France) ML7 dry eye syndrome

development

Ophtalmological diseases Development agreement
2012-05-17 Dako (Denmark) Van Andel Research Institute (USA) MET4 antibody

licensing

Cancer - Oncology Licensing agreement
2012-05-16 Lonza (Switzerland) Avalanche Biotechnologies (USA) adeno-associated viral (AAV) vectors for gene therapy

manufacturing
production

Production agreement
2012-05-16 ReNeuron (UK) Angel Biotechnology (UK) ReN001 stroke

manufacturing
production

Cerebrovascular diseases Production agreement
2012-05-16 Siemens Healthcare Diagnostics France (France) SmartGene (Switzerland) SmartGene HIV-1 Starter Module HIV-Aids

distribution

Infectious diseases Distribution agreement
2012-05-15 Debiopharm (Switzerland) Vifor Pharma (Switzerland) Pamorelin® LA (triptorelin in the form of pamoate salt), Salvacyl® prostate cancer, endometriosis

distribution
commercialisation

Cancer - Oncology - Gynecology - Women's health Commercialisation agreement
2012-05-15 Scil Proteins (Germany) Ono Pharmaceutical (Japan) new Affilin® therapeutics to treat various diseases undisclosed diseases

R&D

undisclosed R&D agreement
2012-05-15 Angel Biotechnology (UK) Cardium Therapeutics (USA) Excellagen® (high molecular weight fibrillar bovine Type I topical gel (2.6%) specifically engineered as an adjunct to debridement for the management of diabetic foot ulcers and other dermal wounds) diabetic foot ulcers and other dermal wounds

manufacturing
production
supply

Metabolic diseases - Cardiovascular diseases Production agreement
2012-05-15 Selexis (Switzerland) Adienne Pharma (Italy) orphan drugs

services

Rare diseases Services contract
2012-05-14 Neurotune (Switzerland) The ALS Therapy Development Institute - ALS TDI (UK) novel class of compounds to maintain neuromuscular junction strength and stability amyotrophic lateral sclerosis Neurodegenerative diseases - Rare diseases Collaboration agreement
2012-05-09 Nuevolution (Denmark) Boehringer Ingelheim (Germany) drug candidates against drug targets of interest to Boehringer Ingelheim

R&D

Milestone
2012-05-09 Evotec (Germany) 4-Antibody (Germany) antibody discovery and development service

R&D
services

Services contract
2012-05-09 Vivalis (France) Biodiem (Australia) use of LAIV (Live Attenuated Influenza Virus) as a vector in Vivalis' proprietary cell line nasopharyngeal carcinoma and respiratory syncytial virus infection Infectious diseases R&D agreement
2012-05-09 Roche 454 Life Sciences (Switzerland - USA) SoftGenetics (USA) NextGENe® software

co-promotion

Technology - Services Co-promotion agreement
2012-05-08 Bayer (Germany) Regeneron Pharmaceuticals (USA) Santen (Japan) EYLEA® (aflibercept) neovascular age-related macular degeneration (wet AMD)

co-promotion

Ophtalmological diseases Co-promotion agreement
2012-05-08 Multiplicom (Belgium) ICAN (France) ICM (France) genetic tests in cardiovascular, metabolic and neurological diseases cardiovascular, metabolic (diabetes...) and neurological diseases

R&D

Cardiovascular diseases - Metabolic diseases - Neurological diseases R&D agreement
2012-05-04 OPKO Health (USA) International Health Technology (UK) kallikrein biomarkers and associated algorithm for the detection of prostate cancer prostate cancer

licensing

Cancer - Oncology Licensing agreement
2012-05-03 Sartorius Stedim (Germany) c-LEcta (Germany) Denarase (Serratia marcescens nuclease for biopharmaceutical applications)

distribution

Distribution agreement